{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:25:18Z","timestamp":1791141918255,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.expneurol.2008.12.015","type":"journal-article","created":{"date-parts":[[2009,1,4]],"date-time":"2009-01-04T04:07:12Z","timestamp":1231042032000},"page":"272-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Functional imaging in Huntington's disease"],"prefix":"10.1016","volume":"216","author":[{"given":"Jane S.","family":"Paulsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2008.12.015_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","article-title":"Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease","volume":"332","author":"Albin","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2008.12.015_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib3","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib4","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archneur.1996.00550120105023","article-title":"Basal ganglia volume and proximity to onset in presymptomatic Huntington's disease","volume":"53","author":"Aylward","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/WNL.48.2.394","article-title":"Longitudinal change in basal ganglia volume in patients with Huntington's disease","volume":"48","author":"Aylward","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","article-title":"Onset and rate of striatal atrophy in preclinical Huntington disease","volume":"63","author":"Aylward","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6\u00a0years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurol."},{"issue":"Pt 12","key":"10.1016\/j.expneurol.2008.12.015_bib9","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"Backman","year":"1997","journal-title":"Brain"},{"issue":"Pt 9","key":"10.1016\/j.expneurol.2008.12.015_bib10","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/brain\/120.9.1553","article-title":"Central motor processing in Huntington's disease. A PET study","volume":"120","author":"Bartenstein","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.wnn.0000152205.79033.73","article-title":"White matter volume and cognitive dysfunction in early Huntington's disease","volume":"18","author":"Beglinger","year":"2005","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib12","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1523\/JNEUROSCI.16-17-05523.1996","article-title":"Expression of normal and mutant huntingtin in the developing brain","volume":"16","author":"Bhide","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.clinpsy.2.022305.095241","article-title":"Methodological and conceptual issues in functional magnetic resonance imaging: applications to schizophrenia research","volume":"2","author":"Brown","year":"2006","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1162\/08989290051137585","article-title":"Imaging cognition II: an empirical review of 275 PET and fMRI studies","volume":"12","author":"Cabeza","year":"2000","journal-title":"J. Cogn. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib15","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.expneurol.2008.12.015_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00001756-200204160-00033","article-title":"Altered functional MRI responses in Huntington's disease","volume":"13","author":"Clark","year":"2002","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2008.12.015_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cercor\/bhh190","article-title":"Basal ganglia and cerebellar inputs to \u2018AIP\u2019","volume":"15","author":"Clower","year":"2005","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2008.12.015_bib18","first-page":"67","article-title":"Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease","volume":"90","author":"Dierks","year":"1999","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.expneurol.2008.12.015_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2008.12.015_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington's disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2008.12.015_bib21","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1212\/WNL.57.11.2083","article-title":"Metabolic correlates of levodopa response in Parkinson's disease","volume":"57","author":"Feigin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.20684","article-title":"Preclinical Huntington's disease: compensatory brain responses during learning","volume":"59","author":"Feigin","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib23","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":"Thalamic metabolism and symptom onset in preclinical Huntington's disease","volume":"130","author":"Feigin","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0306-4522(94)90592-4","article-title":"Value-dependent selection in the brain: simulation in a synthetic neural model","volume":"59","author":"Friston","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.12.015_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington's disease patients","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib26","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.neuropsychologia.2006.12.023","article-title":"Increased cortical recruitment in Huntington's disease using a Simon task","volume":"45","author":"Georgiou-Karistianis","year":"2007","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.expneurol.2008.12.015_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/jnp.2.2.165","article-title":"Assessment of procedural learning and problem solving in schizophrenic patients by Tower fo Hanoi type tasks","volume":"2","author":"Goldberg","year":"1990","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib29","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/01.wnl.0000257090.01107.2f","article-title":"Decreased frontal choline and neuropsychological performance in preclinical Huntington disease","volume":"68","author":"Gomez-Anson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1101\/SQB.1996.061.01.062","article-title":"Huntington's disease","volume":"61","author":"Gusella","year":"1996","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib31","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0404.1987.tb07900.x","article-title":"Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone","volume":"75","author":"Hagglund","year":"1987","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2008.12.015_bib33","series-title":"Eye-Tracking as a Potential Biomarker in Huntington's Disease, 12th International Congress of Parkinson's Disease and Movement Disorders","author":"Hanson","year":"2008"},{"key":"10.1016\/j.expneurol.2008.12.015_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington's disease","volume":"58","author":"Hauser","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.36.7.888","article-title":"Positron emission tomography in the early diagnosis of Huntington's disease","volume":"36","author":"Hayden","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib36","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.37.9.1441","article-title":"The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease","volume":"37","author":"Hayden","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","article-title":"Apoptosis in Huntington's disease","volume":"27","author":"Hickey","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2008.12.015_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000072863","article-title":"The use of transgenic and knock-in mice to study Huntington's disease","volume":"100","author":"Hickey","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.expneurol.2008.12.015_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ana.410340114","article-title":"Positron emission tomography measures of benzodiazepine receptors in Huntington's disease","volume":"34","author":"Holthoff","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0074-7742(05)66009-6","article-title":"Neural modeling and functional brain imaging: the interplay between the data-fitting and simulation approaches","volume":"66","author":"Horwitz","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hbm.10057","article-title":"How can EEG\/MEG and fMRI\/PET data be combined?","volume":"17","author":"Horwitz","year":"2002","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.expneurol.2008.12.015_bib42","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nn1544","article-title":"The cerebellum communicates with the basal ganglia","volume":"8","author":"Hoshi","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2008.12.015_bib44","first-page":"449","article-title":"Macro-architecture of basal ganglia loops with the cerebral cortex: use of rabies virus to reveal multisynaptic circuits","volume":"143","author":"Kelly","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2008.12.015_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pscychresns.2004.03.002","article-title":"Functional MRI study of a serial reaction time task in Huntington's disease","volume":"131","author":"Kim","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.expneurol.2008.12.015_bib46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.53.5.1000","article-title":"Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial","volume":"53","author":"Kremer","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan","volume":"12","author":"Kuhl","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib48","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1002\/ana.410150723","article-title":"Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease","volume":"15 Suppl","author":"Kuhl","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib49","first-page":"199","article-title":"Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease","volume":"63","author":"Kuhl","year":"1985","journal-title":"Res. Publ.- Assoc. Res. Nerv. Ment. Dis."},{"key":"10.1016\/j.expneurol.2008.12.015_bib50","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1531-8249(200005)47:5<644::AID-ANA13>3.0.CO;2-C","article-title":"Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography","volume":"47","author":"Kunig","year":"2000","journal-title":"Ann. Neurol."},{"issue":"Pt 5","key":"10.1016\/j.expneurol.2008.12.015_bib51","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib52","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib53","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","article-title":"Evidence for specific cognitive deficits in preclinical Huntington's disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.870010110","article-title":"Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography","volume":"1","author":"Leenders","year":"1986","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2008.12.015_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pscychresns.2007.10.005","article-title":"Investigating connectivity between the cerebellum and thalamus in schizophrenia using diffusion tensor tractography: a pilot study","volume":"163","author":"Magnotta","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.expneurol.2008.12.015_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198702123160701","article-title":"Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease","volume":"316","author":"Mazziotta","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2008.12.015_bib57","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004647-199903000-00001","article-title":"Mitochondria in neurodegeneration: bioenergetic function in cell life and death","volume":"19","author":"Murphy","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2008.12.015_bib58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington's disease","volume":"48","author":"Myers","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib59","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1176\/appi.ajp.2007.06081266","article-title":"Morphology of the cerebral cortex in preclinical Huntington's disease","volume":"164","author":"Nopoulos","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.expneurol.2008.12.015_bib60","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1523\/JNEUROSCI.0649-07.2007","article-title":"Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease","volume":"27","author":"Pallier","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib61","series-title":"Principles and Practice of Behavioral Neurology and Neuropsychology","first-page":"525","article-title":"Basal ganglia and movement disorders","author":"Paulsen","year":"2004"},{"key":"10.1016\/j.expneurol.2008.12.015_bib62","first-page":"1715","article-title":"fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease","volume":"25","author":"Paulsen","year":"2004","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archneur.63.6.883","article-title":"Preparing for preventive clinical trials: the Predict-HD study","volume":"63","author":"Paulsen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib64","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington's disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2008.12.015_bib65","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM197302152880703","article-title":"Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.","volume":"288","author":"Perry","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2008.12.015_bib67","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ana.20121","article-title":"Functional brain changes in presymptomatic Huntington's disease","volume":"55","author":"Reading","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib68","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.57.6.1025","article-title":"Striatal volume loss in HD as measured by MRI and the influence of CAG repeat","volume":"57","author":"Rosas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib69","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib70","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/00207458308985874","article-title":"Computerized tomographic, neurologic, and neuropsychological correlates of Huntington's disease","volume":"18","author":"Sax","year":"1983","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K","article-title":"Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval","volume":"9","author":"Schacter","year":"1999","journal-title":"Hippocampus"},{"key":"10.1016\/j.expneurol.2008.12.015_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02191583","article-title":"Dopamine D1 receptor number\u2014a sensitive PET marker for early brain degeneration in Huntington's disease","volume":"243","author":"Sedvall","year":"1994","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2008.12.015_bib74","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.neuropsychologia.2006.12.015","article-title":"Verbal episodic memory declines prior to diagnosis in Huntington's disease","volume":"45","author":"Solomon","year":"2007","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.expneurol.2008.12.015_bib75","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/jnnp.51.10.1259","article-title":"Neuropsychological and neuroradiological correlates of Huntington's disease","volume":"51","author":"Starkstein","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2008.12.015_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF00598956","article-title":"Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance study","volume":"34","author":"Starkstein","year":"1992","journal-title":"Neuroradiology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0361-9230(00)00435-4","article-title":"Interpreting PET and fMRI measures of functional neural activity: the effects of synaptic inhibition on cortical activation in human imaging studies","volume":"54","author":"Tagamets","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2008.12.015_bib78","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.2006.098368","article-title":"Functional connectivity of the prefrontal cortex in Huntington's disease","volume":"78","author":"Thiruvady","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2008.12.015_bib79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0962-8924(00)01853-5","article-title":"Huntington's disease: the challenge for cell biologists","volume":"10","author":"Tobin","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib80","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1212\/WNL.49.3.717","article-title":"In vivo studies on striatal dopamine D1 and D2 site binding in l-dopa-treated Parkinson's disease patients with and without dyskinesias","volume":"49","author":"Turjanski","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.12.015_bib81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib83","doi-asserted-by":"crossref","unstructured":"Whitlock, K.B., Stout, J.C., Queller, S., Langbehn, D.R., Carlozzi, N.E., Paulsen, J.S., and Predict-HD Investigators of the Huntington Study Group, 2007. Item Reduction of the University of Pennsylvania Smell ID Test: Preparation for Clinical Trials in pre-HD using the Predict Cohort, Inaugural Huntington Disease Clinical Research Symposium, Boston, MA.","DOI":"10.1016\/j.nurt.2007.10.029"},{"key":"10.1016\/j.expneurol.2008.12.015_bib84","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/brain\/awm210","article-title":"Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI","volume":"130","author":"Wolf","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2008.12.015_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2008.05.017","article-title":"Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease","author":"Wolf","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib86","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00115-007-2390-1","article-title":"[Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers]","volume":"79","author":"Wolf","year":"2008","journal-title":"Nervenarzt"},{"key":"10.1016\/j.expneurol.2008.12.015_bib87","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","article-title":"PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline","volume":"20","author":"Young","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib88","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/archneur.1987.00520150010010","article-title":"Normal caudate glucose metabolism in persons at risk for Huntington's disease","volume":"44","author":"Young","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2008.12.015_bib89","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1017\/S1355617707071214","article-title":"fMRI detection of early neural dysfunction in preclinical Huntington's disease","volume":"13","author":"Zimbelman","year":"2007","journal-title":"J. Int. Neuropsychol. Soc."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608004913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608004913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:38:09Z","timestamp":1758001089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488608004913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0014488608004913"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.12.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional imaging in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}